The dynamic change in HIV subtype distribution presents future challenges for diagnosis,
treatment and vaccine design and development. An increase in recombinant viruses …

Modern drug delivery to tackle infectious disease has drawn close to personalizing medicine
for specific patient populations. Challenges include antibiotic-resistant infections, healthcare …

HIV-1 transmission patterns within and between populations at different risk of HIV-1
acquisition in Kenya are not well understood. We investigated HIV-1 transmission networks …

In Kenya, HIV-1 key populations including men having sex with men (MSM), people who
inject drugs (PWID) and female sex workers (FSW) are thought to significantly contribute to …

Background HIV-1 molecular epidemiology amongst men who have sex with men (MSM) in
sub-Saharan Africa remains not well characterized. We aimed to determine HIV-1 subtype …

Quantification of HIV-1 RNA is essential for clinical management of HIV patients. The limited
throughput and significant hands-on time required by most HIV Viral load (VL) tests makes it …

HIV-1 compartmentalisation is likely to have important implications for a preventative
vaccine as well as eradication strategies. We genetically characterised HIV-1 subtype C …

Introduction HIV-1 viral Load (VL) testing is recommended for the monitoring of antiretroviral
treatment. Dried Blood Spots (DBS) are an effective sample type in resource limited settings …

BACKGROUND: While there is a striking increase in the prevalence of HIV in injection drug
users, information on envelope-gene subtypes and transmission clusters in injection drug …

ABSTRACT HIV infection is currently the single biggest epidemic globally. HIV the etiologic
agent for AIDS is divided into two types: HIV-1 and HIV-2. HIV-2 is rare and is mainly found …